Evidence map›Paper›PMID 41674621›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals.

Subin Choi, Maria Santa Rocca, Cinzia Vinanzi, John Pluta, Zeid Kuzbari, Chey Loveday, Sophie Allen, Beth Torr, Benita Weathers, Lynn Anson-Cartwright and 15 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Subin ChoiDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0003-3772-2843
Maria Santa RoccaHospital University of Padova, Unit of Andrology and Reproductive Medicine, via N. Giustiniani 2, 35128 Padova, Italy.ORCID 0000-0002-4794-9745
Cinzia VinanziHospital University of Padova, Unit of Andrology and Reproductive Medicine, via N. Giustiniani 2, 35128 Padova, Italy.
John PlutaDivision of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, USA.ORCID 0000-0002-8941-6242
Zeid KuzbariDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0001-7856-1578
Chey LovedayDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-2291-372X
Sophie AllenDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0003-4928-2240
Beth TorrDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0003-3487-9749
Benita WeathersDivision of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, USA.ORCID 0000-0002-5675-8334
Lynn Anson-CartwrightDepartment of Surgery (Urology), University of Toronto and The Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-7726-9695
Darren R FeldmanDepartment of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-2424-4635
Jourik A GietemaDepartment of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.ORCID 0000-0003-0629-7354
Anna Gonzalez-NeiraHuman Genotyping Unit-CeGen, Cancer Genomics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.ORCID 0000-0002-5421-2020
Robert J HamiltonDepartment of Surgery (Urology), University of Toronto and The Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-6715-5934
Csilla KrauszDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.ORCID 0000-0001-6748-8918
Giovenale MoiranoDepartment of Medical Sciences, University of Turin and CPO-Piemonte, 10121 Turin, Italy.ORCID 0000-0001-8748-3321
Kevin T NeadDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-9680-8298
Jérémie NsengimanaBiostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-3603-4208
Jenny N PoynterDepartment of Pediatrics, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-8460-3938
David J VaughnDivision of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, USA.
Peter A KanetskyDepartment of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0002-5567-9618
Katherine L NathansonDivision of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, USA.ORCID 0000-0002-6740-0901
Alberto FerlinHospital University of Padova, Unit of Andrology and Reproductive Medicine, via N. Giustiniani 2, 35128 Padova, Italy.ORCID 0000-0001-5817-8141
Clare TurnbullDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-1734-5772
Charlie F RowlandsDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0001-5333-4846

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Post GWA Studies in Testicular Germ Cell TumorsU01CA164947 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KANETSKY, PETER A, NATHANSON, KATHERINE L. · 2012 to 2024
$11.7M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016672NCI NIH HHS U01 CA164947Wellcome Trust
6 · The paper itself

Abstract

Purpose: Germline deletions affecting the Y-chromosomal gr/gr region were reported in 2005 as associated with susceptibility to testicular germ cell tumor (TGCT), a highly heritable tumor type that is the most common cancer type affecting adult men under the age of 45. Attempts to replicate this association have been equivocal, primarily due to limited power. Methods: Here, we compare and validate two computational approaches to gr/gr deletion calling in high-, low- and ultra-low-coverage whole genome sequencing data, applying these to two datasets from UK Biobank and the TECAC consortium. We generate dataset-specific effect size estimates for the gr/gr deletion-TGCT association using Firth's bias-reduced logistic regression across a total of 198,306 men of European-like ancestry (2231 with and 196,075 without TGCT). Results: Upon random-effects meta-analysis of estimated effect sizes in the two datasets, we found no significant association between gr/gr deletion status and TGCT risk (combined odds ratio=1.24, 95% CI=0.74-2.07, p=0.42), nor upon stratification of seminoma and non-seminoma/mixed histological subtypes. Conclusion: Our analysis suggests gr/gr deletion status alone is likely not predictive of TGCT risk in population-scale analyses of European-like individuals; however, the importance of other proposed determinants of gr/gr deletion impact, including Y-haplogroups and semen phenotype, remains unexplored at scale.

Identifiers

PMID41674621
PMCPMC12889780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.